Personalized_Medicine_A_New_Medical_and_Social_Challenge

underexpressed proteins that are detected by IMS significantly improved the chances of this technology to be used for personaliz ...

and preliminary validation of biomarker candidates for the early detection of cancer^101 and cancer metastasis^102 and for such ...

early-stage ischemic identification at a point prior to cell death.^115 Recent advances in quantitative proteomic approaches dem ...

treatment with slimming pills containingAristolochia fangchi, an herb that is frequently a component in several mixtures of plan ...

and one locus at the chromosome 22q12 indicates an increased risk for this type of nephropathy.^131 Quantitative proteomic analy ...

In majority cases of age-dependent Alzheimer’s and Parkinson’s disease that appear sporadic in the advanced age, the protein agg ...

oxidative modification of a large number of proteins. These results also indicate that mitochondria are the organelles where the ...

quantitative proteomics for the analysis of cerebrospinal fluid of Parkinson’s patients and healthy controls. They recommend two ...

that their cumulative expression profile reflects the specific activity of cells. Prote- omics are an important tool for underst ...

sample processing, biomarker discovery, and validation for DM was recently presented by Shao et al.^173 The authors present comp ...

prerequisite for the understanding of basic disease-causing mechanisms and devel- opment of new approaches in allergy treatment. ...

Knowledge about structure–function relationship of IgE antibody, a key player in allergies, is still fragmentary. An IgE antibod ...

the “omics” are useful tools to (1) more thoroughly describe the biological response of humans in space, (2) describe molecular ...

References Adam BL, Qu Y, Davis YW, Ward MD, Clements MA et al (2002) Serum protein fingerprinting coupled with a pattern-matchi ...

kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33:562–571 Castegna A, Aksenov ...

Drake JM, Graham NA, Lee JK, Stoyanova T, Faltermeier CM, Sud S et al (2013) Metastatic castration-resistant prostate cancer rev ...

Hoffman RM (2011) Screening for prostate cancer. N Engl J Med 365:2013–2019 Hood LE, Omenn GS, Moritz RL, Aebersold R, Yamamoto ...

Le Founder J, Laouirem S, Chapelle M, Albuquerque M, Belghiti J et al (2011) Imaging mass spectrometry provides fingerprints for ...

Pavelic K, Martinovic T, Kraljevic Pavelic S (2015) Do we understand personalized medicine paradigm? EMBO Rep 16:133–136. doi:10 ...

Schiffer E (2011) Urinary proteomics: ready for prime time in urological cancer diagnosis. Future Med 8:81–94 Schmidt MA, Goodwi ...